When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

UBI provides regular, unconditional cash payments to individuals without work requirements. Largest UBI trial in Kenya improved medical access and business startup rates. UBI's high cost and potential ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

This assignment focuses on syntactic specification in PLCC. You will define grammars, build parsers and basic interpretation using PLCC. By completing this assignment, you'll gain hands-on experience ...

Long-Term Support release, with features ranging from structured concurrency and compact object headers to ahead-of-time method profiling and JFR CPU-time profiling on Linux, is now generally ...

Learn how to use pattern-matching features in your Java programs, including pattern matching with switch statements, when clauses, sealed classes, and a preview of primitive type pattern matching in ...

This repository is perfect for Java beginners - inside, you'll find clear examples covering everything from basic syntax, variables, and control statements to OOP concepts, arrays, exception handling, ...

Recursion Pharmaceuticals (RXRX), a trailblazer in AI-powered drug discovery, recently acquired its competitor, Exscientia, in a strategic move that solidifies its leading position in the industry.